The Cochrane review of electronic cigarettes for smoking cessation: remaining focused on the evidence
Eur Respir J
.
2021 Oct 7;58(4):2102117.
doi: 10.1183/13993003.02117-2021.
Print 2021 Oct.
Authors
Caitlin Notley
1
,
Ailsa R Butler
2
,
Nicola Lindson
3
,
Chris Bullen
4
,
Annika Theodoulou
2
,
Rachna Begh
2
,
Hayden McRobbie
5
6
,
Peter Hajek
7
,
Nancy Rigotti
8
,
Jamie Hartman-Boyce
3
Affiliations
1
University of East Anglia, Medical School, Norwich, UK C.Notley@uea.ac.uk.
2
University of Oxford, Oxford, UK.
3
University of Oxford, Medical Sciences Division, Nuffield Dept of Primary Care Health Sciences, Oxford, UK.
4
University of Auckland, Auckland, New Zealand.
5
University of New South Wales, National Drug and Alcohol Research Centre, Sydney, Australia.
6
Lakes District Health Board, Rotorua, New Zealand.
7
Wolfson Institute of Preventive Medicine, London, UK.
8
Harvard Medical School, MGH Tobacco Research and Treatment Center, Boston, MA, USA.
PMID:
34446470
DOI:
10.1183/13993003.02117-2021
No abstract available
Publication types
Letter
Comment
MeSH terms
Electronic Nicotine Delivery Systems*
Humans
Nicotine
Smoking Cessation*
Smoking Prevention
Substances
Nicotine
Grants and funding
29845/CRUK_/Cancer Research UK/United Kingdom